Long-term survival in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: follow-up of a multicentre randomised trial

被引:11
|
作者
Cao, Shuang-Jie [1 ]
Zhang, Yue [1 ,2 ]
Zhang, Yu-Xiu [1 ]
Zhao, Wei [3 ]
Pan, Ling -Hui [4 ]
Sun, Xu-De [5 ]
Jia, Zhen [6 ]
Ouyang, Wen [7 ]
Ye, Qing-Shan [8 ]
Zhang, Fang -Xiang [9 ]
Guo, Yong-Qing [10 ]
Ai, Yan-Qiu [11 ]
Zhao, Bin -Jiang [12 ]
Yu, Jian-Bo [13 ]
Liu, Zhi-Heng [14 ]
Yin, Ning [15 ,16 ]
Li, Xue-Ying [17 ]
Ma, Jia-Hui [1 ]
Li, Hui -Juan [18 ]
Wang, Mei-Rong [18 ]
Sessler, Daniel I. [19 ,21 ]
Ma, Daqing [20 ,22 ]
Wang, Dong-Xin [1 ,19 ]
机构
[1] Peking Univ First Hosp, Dept Anesthesiol, Beijing, Peoples R China
[2] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Clin Res Inst, Shenzhen, Peoples R China
[3] Hebei Med Univ, Dept Anesthesiol, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[4] Guangxi Med Univ, Dept Anesthesiol, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi Zhuang, Peoples R China
[5] Fourth Mil Med Univ, Air Force Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China
[6] Qinghai Univ, Dept Anesthesiol, Affiliated Hosp, Xining, Qinghai, Peoples R China
[7] Cent South Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China
[8] Peoples Hosp Ningxia Hui Autonomous Reg, Dept Anesthesiol, Yinchuan, Ningxia Hui Aut, Peoples R China
[9] Guizhou Prov Peoples Hosp, Dept Anesthesiol, Guiyang, Guizhou, Peoples R China
[10] Shanxi Prov Peoples Hosp, Dept Anesthesiol, Taiyuan, Shanxi, Peoples R China
[11] Zhengzhou Univ, Dept Anesthesiol Pain & Perioperat Med, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[12] Capital Med Univ, Beijing Shijitan Hosp, Dept Anesthesiol, Beijing, Peoples R China
[13] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol & Crit Care Med, Tianjin, Peoples R China
[14] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Anesthesiol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[15] Southeast Univ, Zhongda Hosp, Med Sch, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China
[16] Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China
[17] Peking Univ First Hosp, Dept Biostat, Beijing, Peoples R China
[18] Peking Univ, Clin Res Inst, Hlth Sci Ctr, Beijing, Peoples R China
[19] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA
[20] Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Div Anaesthet Pain Med & Intens Care,Dept Surg &, London, England
[21] Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH USA
[22] Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China
关键词
aged; cancer surgery; inhalation anaesthesia; intravenous anaesthesia; morbidity; propofol; sevoflurane; survival; TOTAL INTRAVENOUS ANESTHESIA; GENERAL-ANESTHESIA; METASTASIS; VOLATILE; LIFE; ISOFLURANE; QUALITY; PATHWAY;
D O I
10.1016/j.bja.2023.01.023
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Experimental evidence indicates that i.v. anaesthesia might reduce cancer recurrence compared with volatile anaesthesia, but clinical information is observational only. We therefore tested the primary hypothesis that propofol-based anaesthesia improves survival over 3 or more years after potentially curative major cancer surgery. Methods: This was a long-term follow-up of a multicentre randomised trial in 14 tertiary hospitals in China. We enrolled 1228 patients aged 65 - 90 yr who were scheduled for major cancer surgery. They were randomised to either propofolbased i.v. anaesthesia or to sevoflurane-based inhalational anaesthesia. The primary endpoint was overall survival after surgery. Secondary endpoints included recurrence -free and event -free survival. Results: Amongst subjects randomised, 1195 (mean age 72 yr; 773 [65%] male) were included in the modified intention -totreat analysis. At the end of follow-up (median 43 months), there were 188 deaths amongst 598 patients (31%) assigned to propofol-based anaesthesia compared with 175 deaths amongst 597 patients (29%) assigned to sevoflurane-based anaesthesia; adjusted hazard ratio 1.02; 95% confidence interval (CI): 0.83 - 1.26; P = 0.834. Recurrence -free survival was 223/598 (37%) in patients given propofol anaesthesia vs 206/597 (35%) given sevoflurane anaesthesia; adjusted hazard ratio 1.07; 95% CI: 0.89 - 1.30; P = 0.465. Event -free survival was 294/598 (49%) in patients given propofol anaesthesia vs 274/ 597 (46%) given sevoflurane anaesthesia; adjusted hazard ratio 1.09; 95% CI 0.93 to 1.29; P = 0.298. Conclusions: Long-term survival after major cancer surgery was similar with i.v. and volatile anaesthesia. Propofol-based iv. anaesthesia should not be used for cancer surgery with the expectation that it will improve overall or cancer -specific survival. Clinical trial registrations: ChiCTR-IPR-15006209; NCT02660411.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
  • [41] Long-Term Follow-Up of Patients with Hypoparathyroidism
    Mitchell, Deborah M.
    Regan, Susan
    Cooley, Michael R.
    Lauter, Kelly B.
    Vrla, Michael C.
    Becker, Carolyn B.
    Burnett-Bowie, Sherri-Ann M.
    Mannstadt, Michael
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4507 - 4514
  • [42] Long-term follow-up of patients with candiduria
    Revankar, S. G.
    Hasan, M. S.
    Revankar, V. S.
    Sobel, J. D.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (02) : 137 - 140
  • [43] A long-term follow-up of stroke patients
    Wilkinson, PR
    Wolfe, CDA
    Warburton, FG
    Rudd, AG
    Howard, RS
    RossRussell, RW
    Beech, RR
    [J]. STROKE, 1997, 28 (03) : 507 - 512
  • [44] Laparoscopic surgery and reports on "long-term" follow-up
    B.J. Ammori
    [J]. Surgical Endoscopy And Other Interventional Techniques, 2003, 17 : 662 - 663
  • [45] A LONG-TERM FOLLOW-UP OF PATIENTS WITH SILICOSIS
    BUCCA, C
    AVOLIO, G
    ROLLA, G
    MAINA, A
    BUGIANI, M
    AROSSA, W
    SPINACI, S
    CACCIABUE, M
    [J]. BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1985, 21 (01): : A8 - A9
  • [46] Long-term follow-up of patients with hyperprolactinaemia
    Jeffcoate, WJ
    Pound, N
    Sturrock, NDC
    Lambourne, J
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (03) : 299 - 303
  • [47] LONG-TERM FOLLOW-UP OF PATIENTS WITH GASTROSCHISIS
    SWARTZ, KR
    HARRISON, MW
    CAMPBELL, JR
    CAMPBELL, TJ
    [J]. AMERICAN JOURNAL OF SURGERY, 1986, 151 (05): : 546 - 549
  • [48] Long-term follow-up of asthmatic patients
    Postma, DS
    Panhuysen, CIM
    Gerritsen, J
    Koeter, GH
    [J]. FROM GENETICS TO QUALITY OF LIFE: THE OPTIMAL TREATMENT AND MANAGEMENT OF ASTHMA, 1996, : 127 - 132
  • [49] LONG-TERM FOLLOW-UP OF HYPOSPADIAS PATIENTS
    SOMMERLAD, BC
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 1975, 28 (04): : 324 - 330
  • [50] LONG-TERM FOLLOW-UP OF ICU PATIENTS
    FRIEDMAN, BC
    BOYCE, W
    BEKES, CE
    [J]. CLINICAL RESEARCH, 1990, 38 (03): : A733 - A733